Latest filing published 13 Jan 2016 for NEVRO CORP.
Insider track record
No signal scores available.
Doug Alleavitch: trading record in brief
Doug Alleavitch discloses dealings in Nevro Corp to SEC (Form 4). In total, 25 filings cover trades dated from 4 January 2016 to 25 November 2019.
No open-market purchase appears, only 16 sales worth €1.2M. Outside the open market, there are 6 share grants and 3 option exercises. So far in 2019, the count stands at no purchases and 2 sales.
The record was last updated on 26 November 2019 with an open-market sale (€100k) in Nevro Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Doug Alleavitch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 sharesCommon StockSEC:0001140361-16-047731:0
- 300 sharesCommon StockSEC:0001140361-16-046943:0
- 700 sharesCommon StockSEC:0001140361-16-046943:1
- 500 sharesCommon StockSEC:0001140361-16-046943:2
- 1,014 sharesCommon StockSEC:0001140361-16-046943:3
5 of 5 declarations
